Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010078063) IN-SITU REFILLABLE OPHTHALMIC IMPLANT
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/078063 International Application No.: PCT/US2009/068613
Publication Date: 08.07.2010 International Filing Date: 18.12.2009
IPC:
A61F 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
F
FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
9
Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
Applicants:
ALCON RESEARCH, LTD. [US/US]; 6201 South Freeway Mail Code TB4-8 Fort Worth, Texas 76134-2099, US (AllExceptUS)
WEINER, Alan L. [US/US]; US (UsOnly)
Inventors:
WEINER, Alan L.; US
Agent:
SCOTT A. CHAPPLE; Alcon Research, LTD. IP Legal, Mail Code TB4-8 6201 South Freeway Fort Worth, Texas 76134-2099, US
Priority Data:
61/142,24202.01.2009US
Title (EN) IN-SITU REFILLABLE OPHTHALMIC IMPLANT
(FR) IMPLANT OPHTALMIQUE RECHARGEABLE IN SITU
Abstract:
(EN) The present invention is directed to an in-situ refillable ophthalmic implant (10) having a refill port (28) in communication with a reservoir (14) and a release control mechanism (24). The present invention also relates to methods of forming and using the ophthalmic implant. Preferably, the control release mechanism include opening [s] (50) providing for passive passage of pharmaceutical ophthalmic composition, particularly therapeutic agent, out of the reservoir, through the opening [s] and into the eye.
(FR) La présente invention vise un implant ophtalmique (10) rechargeable in situ, doté d'un orifice de rechargement (28) qui communique avec un réservoir (14) et d'un mécanisme (24) de contrôle de la libération. La présente invention concerne également des procédés de formation et d'utilisation de l'implant ophtalmique. Le mécanisme de contrôle de la libération comprend de préférence une ou plusieurs ouvertures (50) qui permettent un passage passif d'une composition ophtalmique pharmaceutique, en particulier d'un agent thérapeutique, hors du réservoir, à travers la ou les ouvertures et jusque dans l'oeil.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
MXMX/a/2011/006726EP2379027JP2012514493CN102271632CA2750178MX2011006726
KR1020110119681BRPI0923810AU2009333100